Product Information

RIZATRIPTAN 10 MG ODT is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.5237 per EA under NDC 33342009441. Its NADAC has been published 424 times since Oct 10, 2018.

FDA first approved this application on Sep 19, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIZATRIPTAN 10 MG ODT

rizatriptan benzoate
$0.5237per EA

Strength

10 mg/1

NDC

33342009441

Classification

Generic

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

RIZATRIPTAN BENZOATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203146

FDA Approved

9/19/2014

TE Code

AB

On Market Since

9/23/2014

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for RIZATRIPTAN 10 MG ODT has been published 424 times since Oct 10, 2018, and over the history we have for it it has declined 49.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5237 per EA
All-time high$1.2669 (Aug 12, 2020)
All-time low$0.4145 (Nov 20, 2024)
52-week high$0.5544
52-week low$0.5097
Median price$0.7353
Average price$0.7941
Largest weekly change-31.5% (Nov 20, 2024)
Weeks tracked424
Tracking sinceOct 10, 2018

Price History

1W

+0.4%

1M

+2.8%

3M

+2.6%

6M

-2.0%

1Y

-5.5%

3Y

-16.0%

5Y

-42.5%

All

-49.1%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIZATRIPTAN 10 MG ODT?

The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 10 MG ODT, manufactured by Macleods Pharmaceuticals Limited, is $0.5237 per EA (NDC 33342009441), effective Nov 18, 2026.

How has the price of RIZATRIPTAN 10 MG ODT changed over time?

Over the history we have for it, the NADAC for RIZATRIPTAN 10 MG ODT has declined 49.1%. It has been tracked across 424 weekly CMS publications since Oct 10, 2018.

What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 10 MG ODT?

Since Oct 10, 2018, the NADAC for RIZATRIPTAN 10 MG ODT has ranged from a low of $0.4145 (Nov 20, 2024) to a high of $1.2669 (Aug 12, 2020), with a median of $0.7353 per EA.

Are there cheaper alternatives to RIZATRIPTAN 10 MG ODT?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 10 MG TABLET, is $0.5115 per EA — about 2% below RIZATRIPTAN 10 MG ODT.

Who manufactures RIZATRIPTAN 10 MG ODT?

RIZATRIPTAN 10 MG ODT (NDC 33342009441) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.